Treatment of metabolic disorders
US7645772B2 · kind B2 · utility
3Cited by
9References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2003 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Mar 2, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.